GlassScriptPhysician profile
Javier Suarez-Jaramillo
NPI 1972045664
$4,136.40
in general payments reported to CMS, 2019-2025
15 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $571 · 2022: $1,298 · 2023: $501 · 2024: $1,655 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,243 · Education: $24.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,243.42 |
| Education | $24.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $1,140.97 | 2021-2024 | Jornay Pm |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $637.74 | 2021-2024 | Caplyta |
| Teva Pharmaceuticals USA, INC. | $532.19 | 2022-2024 | Austedo Xr, Uzedy, Austedo |
| Abbvie INC. | $417.90 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $245.21 | 2022-2024 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Neurocrine Biosciences, INC. | $230.01 | 2022-2024 | Ingrezza |
| Corium, LLC | $161.24 | 2021-2024 | Azstarys |
| Vanda Pharmaceuticals INC. | $154.85 | 2024 | Fanapt |
| E.R. Squibb & Sons, L.L.C. | $150.97 | 2024-2025 | Cobenfy |
| Axsome Therapeutics, INC. | $146.26 | 2024-2025 | Auvelity |
| Alkermes, INC. | $106.72 | 2021-2024 | Aristada, Lybalvi |
| Lundbeck LLC | $74.01 | 2024 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $66.18 | 2022-2023 | Trintellix |
| Sunovion Pharmaceuticals INC. | $52.05 | 2021-2022 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $20.10 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Javier Suarez-Jaramillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.